Based on Olink's proximity ligation technology, Duolink allows for detection of low-abundance proteins with higher specificity than conventional immunoassays.
Sigma-Aldrich will participate in the university's Catalyst Program, which is designed to support translation of early biomedical discoveries into commercial products.
Sigma-Aldrich is selling the business in order to gain approval from the EC for its $17 billion acquisition by Merck KGaA announced a year ago.
The arrayed lentiviral CRISPR/Cas9 guide RNA libraries provide the tools to knock out every known human or mouse protein-coding gene.
Sigma-Aldrich will distribute IROA's Mass Spectrometry Metabolite Library of Standards worldwide.
Sigma-Aldrich still must meet certain requirements to sell parts of its solvents and inorganics business in Europe to complete the acquisition.
The three-year deal includes more than 100,000 pre-designed assays for public domain human SNPs.
The slight sales decline included a 9 percent negative impact from foreign currency exchange.
The company achieved ISO 13485 certification for two facilities, extending their capabilities to manufacture and offer raw materials used in diagnostic assays.
Sigma-Aldrich has been developing reagents for the Genius platform for about a year.
The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.
In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.
MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.
In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.